Report cover image

Sanger Sequencing Service Market: Current Analysis and Forecast (2022-2028)

Publisher UnivDatos Market Insights
Published Mar 10, 2023
Length 154 Pages
SKU # Univ17870609

Description

Sanger Sequencing Service Market: Current Analysis and Forecast (2022-2028)

Sanger sequencing is one of the oldest DNA sequencing methods which utilizes dideoxynucleotides to sequence DNA. It is frequently used for the sequencing of plasmid DNA, polymerase chain reaction (PCR) products, and bacterial artificial chromosomes (BAC) and is the most preferred choice for mutation detection. The sanger sequencing service market is growing tremendously due to its wide range of applications in the diagnosis of chronic diseases, unmet need for personalized medicine, and surge in the prevalence of rare genetic diseases.

The Sanger Sequencing Service Market is expected to grow at a strong CAGR of 10% during the forecast period owing to the surge in the prevalence of various cancers and rising awareness regarding the diagnosis of cancer. The American Cancer Society Journal estimates that approximately 140,690 people in the U.S. are diagnosed with cancer each year and that 103,250 people pass away from cancer each year. In addition, the World Health Organization (WHO) cites cancer as the second leading cause of death worldwide. Moreover, the increase in the prevalence of rare genetic diseases and the surge in the demand for personalized medicine are also positively impacting the growth of the market.
  • Based on application, the market is segmented into diagnostics, biomarkers and cancer, reproductive health, personalized medicine, forensics, and others. The biomarkers and cancer segment held the dominant share of the market in 2021 which is mainly due to the surge in the prevalence of cancer, high demand for advanced sanger systems and services for the identification of cancer biomarkers, and rising investment for ongoing cancer research. Apart from this, sanger sequencing can also be used in drug development to identify potential targets for cancer therapies. Moreover, strategic developments undertaken by market players are also anticipated to bolster the market's growth over the analysis period. For instance, in March 2022, Vela Diagnostics released new next-generation sequencing (NGS)-based panels to detect RNA and DNA cancer biomarkers from formalin-fixed paraffin-embedded (FFPE) tissue specimens.
  • On the basis of end user, the market is segmented into academics and governmental organizations, pharmaceutical companies, hospitals & clinics, and others. Pharmaceutical companies are anticipated to grow with a high CAGR during the forecast period. This is mainly attributed to the surge in the number of research projects across a wide range of applications such as drug discovery and development, diagnosis, human health mapping, population studies, and others.
  • For a better understanding of the market adoption of the Sanger Sequencing Service industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America held the dominant share of the market in 2021. The market is driven by increasing demand for personalized medicine, genomics research, and agricultural and food sciences. Moreover, the market is highly competitive, with several key players offering a range of sequencing services to academic and commercial customers. In addition to this, companies are rapidly expanding their services in North America, which will also have a positive impact on the growth of the market during the forecast period. For instance, in August 2022, Source Bioscience launched sanger sequencing service in San Diego to support life science researchers with market leading genomic services.
  • Some of the major players operating in the market include Microsynth AG; Thermo Fisher Scientific, Inc.; Azenta Life Sciences; GenHunter Corporation; LGC Biosearch Technologies; Laragen, Inc; STARSEQ GmbH; Medisupport SA; Quintara; and ciGenom Labs Pvt. Ltd.

Table of Contents

154 Pages
1 MARKET INTRODUCTION
1.1. Market Definitions
1.2. Main Objective
1.3. Stakeholders
1.4. Limitation
2 RESEARCH METHODOLOGY OR ASSUMPTION
2.1. Research Process of the Sanger Sequencing Service Market
2.2. Research Methodology of the Sanger Sequencing Service Market
2.3. Respondent Profile
3 MARKET SYNOPSIS
4 EXECUTIVE SUMMARY
5 IMPACT OF COVID-19 ON THE SANGER SEQUENCING SERVICE MARKET
6 SANGER SEQUENCING SERVICE MARKET REVENUE (USD BN), 2020-2028F
7 MARKET INSIGHTS BY APPLICATION
7.1. Diagnostics
7.2. Biomarkers and Cancer
7.3. Reproductive Health
7.4. Personalized Medicine
7.5. Forensics
7.6. Others
8 MARKET INSIGHTS BY END USER
8.1. Academic & Government Research Institutes
8.2. Pharmaceutical Companies
8.3. Hospitals & Clinics
8.4. Others
9 MARKET INSIGHTS BY REGION
9.1. North America
9.1.1. U.S.
9.1.2. Canada
9.1.3. Rest of North America
9.2. Europe
9.2.1. Germany
9.2.2. U.K.
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia-Pacific
9.3.1. China
9.3.2. Japan
9.3.3. India
9.3.4. Rest of Asia-Pacific
9.4. Rest of World
10 SANGER SEQUENCING SERVICE MARKET DYNAMICS
10.1. Market Drivers
10.2. Market Challenges
11 SANGER SEQUENCING SERVICE MARKET OPPORTUNITIES
12 SANGER SEQUENCING SERVICE MARKET TRENDS
13 DEMAND AND SUPPLY-SIDE ANALYSIS
13.1. Demand Side Analysis
13.2. Supply Side Analysis
14 VALUE CHAIN ANALYSIS
15 COMPETITIVE SCENARIO
15.1. Competitive Landscape
15.1.1. Porters Fiver Forces Analysis
16 COMPANY PROFILED
16.1. Microsynth AG
16.2. Thermo Fisher Scientific, Inc.
16.3. Azenta Life Sciences
16.4. GenHunter Corporation
16.5. LGC Biosearch Technologies
16.6. Laragen, Inc
16.7. STARSEQ GmbH
16.8. Medisupport SA
16.9. Quintara
16.10. SciGenom Labs Pvt. Ltd.
17 DISCLAIMER

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us